logo
Plus   Neg
Share
Email

HHLA Prelim. FY18 Operating Result Rises; Group Revenue Up 3% - Quick Facts

Hamburger Hafen und Logistik AG (HHULF.PK,HHULY.PK) reported that, according to preliminary unaudited figures, the Group's operating result (EBIT) was 204 million euros for fiscal 2018 compared to 173 million euros, prior year, an increase of 18 percent. The listed Port Logistics subgroup generated an operating result of 188 million euros, for the fiscal year.

According to preliminary unaudited figures, HHLA increased its Group revenue by 3 percent to 1.29 billion euros in the 2018 financial year from 1.25 billion euros, prior year. The listed Port Logistics subgroup generated revenue of 1.26 billion euros compared to 1.22 billion euros, prior year.

Chairwoman of the Executive Board of Hamburger Hafen und Logistik AG (HHLA), Angela Titzrath, said: "HHLA has performed very successfully over the past financial year, despite the deterioration of the market environment in the second half. The challenging targets we set for ourselves one year ago have been achieved and partially exceeded."

HHLA will publish the 2018 Annual Report and a business forecast for the 2019 financial year on 27 March 2019.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Just Egg, a plant-based egg alternative, will be available in 2,100 stores owned by grocery chain Kroger Co. later this month. The product launch comes as plant-based meat and egg alternatives gain traction in the country. Just Egg, a product of California-based food technology company Just Inc., will be available at Kroger-owned stores, including Kroger, Fred Meyer and Ralphs. Boeing has delivered the first 787-10 Dreamliner to Vietnam Airlines, the flag carrier of Vietnam, as part of the eight 787-10 Dreamliner airplanes to be delivered on lease through Air Lease. Vietnam Airlines said the 787-10 Dreamliner, claimed by Boeing to be the most fuel-efficient twin-aisle airplane in the industry, will help it raise the customer experience on the Hanoi to Ho Chi Minh route. The U.S. Food and Drug Administration or FDA announced on its website that pharma major Pfizer, Inc. issued recall of two lots of tablets meant to treat acute migraine in adults for concerns over bacteria infection. The pharma company is recalling two lots of Relpax (eletriptan hydrobromide) 40 mg tablets for potential presence of Genus Pseudomonas and Burkholderia bacteria.
Follow RTT